Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative-Reference-Cited by-同舟云学术

Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative

Published:2019-11-20 Issue:2 Volume:40 Page:231-245
ISSN:0271-678X
Container-title:Journal of Cerebral Blood Flow & Metabolism
language:en
Short-container-title:J Cereb Blood Flow Metab

Author:

De Guio François¹,Duering Marco²³,Fazekas Franz⁴,De Leeuw Frank-Erik⁵,Greenberg Steven M⁶,Pantoni Leonardo⁷^ORCID,Aghetti Agnès¹,Smith Eric E⁸,Wardlaw Joanna⁹^ORCID,Jouvent Eric¹

Affiliation:

1. Department of Neurology and Referral Center for Rare Vascular Diseases of the Brain and Retina (CERVCO), APHP, Lariboisière Hospital, Paris, DHU NeuroVasc, Univ Paris Diderot, and U1141 INSERM, France

2. Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Germany

3. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

4. Department of Neurology, Medical University of Graz, Graz, Austria

5. Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, Radboud University, Nijmegen, The Netherlands

6. Department of Neurology, Stroke Research Center, Massachusetts General Hospital, Boston, MA, USA

7. “Luigi Sacco” Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy

8. Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada

9. Centre for Clinical Brain Sciences, Edinburgh Imaging, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK

Abstract

Brain atrophy is increasingly evaluated in cerebral small vessel diseases. We aim at systematically reviewing the available data regarding its extent, correlates and cognitive consequences. Given that in this context, brain atrophy measures might be biased, the first part of the review focuses on technical aspects. Thereafter, data from the literature are analyzed in light of these potential limitations, to better understand the relationships between brain atrophy and other MRI markers of cerebral small vessel diseases. In the last part, we review the links between brain atrophy and cognitive alterations in patients with cerebral small vessel diseases.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0271678X19888967

Reference61 articles.

1. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

2. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging

3. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

4. Cerebral Atrophy in Cerebrovascular Disorders

5. Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular cognitive impairment: Advances in clinical research and management;Chinese Medical Journal;2024-07-24

2. Identification of Distinct Brain MRI Phenotypes and Their Association With Long-Term Dementia Risk in Community-Dwelling Older Adults;Neurology;2024-04-09

3. Discontinuity of deep medullary veins in SWI is associated with deep white matter hyperintensity volume and cognitive impairment in cerebral small vessel disease;Journal of Affective Disorders;2024-04

4. Plasma homocysteine level, estradiol level, and brain atrophy: a Mendelian randomization study;Cerebral Cortex;2024-03-01

5. Démarche diagnostique devant une leucopathie vasculaire;Pratique Neurologique - FMC;2024-03